Great Bay Bio

Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater Bay Area, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.

Great Bay Bio headquartered in Asia, operates in the Biotechnology, Life Science, Biopharma sector. The company focuses on Biotechnology and has secured $1.3B in funding across 48 round(s). With a team of 101-250 employees, Great Bay Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Great Bay Bio, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.